收费全文 | 24502篇 |
免费 | 1761篇 |
国内免费 | 51篇 |
耳鼻咽喉 | 192篇 |
儿科学 | 814篇 |
妇产科学 | 858篇 |
基础医学 | 3096篇 |
口腔科学 | 533篇 |
临床医学 | 3485篇 |
内科学 | 4059篇 |
皮肤病学 | 478篇 |
神经病学 | 2245篇 |
特种医学 | 537篇 |
外科学 | 2555篇 |
综合类 | 494篇 |
一般理论 | 25篇 |
预防医学 | 2880篇 |
眼科学 | 428篇 |
药学 | 1577篇 |
中国医学 | 23篇 |
肿瘤学 | 2035篇 |
2023年 | 137篇 |
2022年 | 195篇 |
2021年 | 499篇 |
2020年 | 361篇 |
2019年 | 509篇 |
2018年 | 537篇 |
2017年 | 419篇 |
2016年 | 480篇 |
2015年 | 527篇 |
2014年 | 753篇 |
2013年 | 1077篇 |
2012年 | 1681篇 |
2011年 | 1804篇 |
2010年 | 953篇 |
2009年 | 783篇 |
2008年 | 1552篇 |
2007年 | 1585篇 |
2006年 | 1485篇 |
2005年 | 1495篇 |
2004年 | 1471篇 |
2003年 | 1374篇 |
2002年 | 1146篇 |
2001年 | 371篇 |
2000年 | 372篇 |
1999年 | 345篇 |
1998年 | 263篇 |
1997年 | 244篇 |
1996年 | 183篇 |
1995年 | 171篇 |
1994年 | 179篇 |
1993年 | 146篇 |
1992年 | 287篇 |
1991年 | 248篇 |
1990年 | 218篇 |
1989年 | 203篇 |
1988年 | 171篇 |
1987年 | 187篇 |
1986年 | 182篇 |
1985年 | 175篇 |
1984年 | 142篇 |
1983年 | 142篇 |
1982年 | 101篇 |
1981年 | 95篇 |
1980年 | 88篇 |
1979年 | 103篇 |
1978年 | 98篇 |
1977年 | 66篇 |
1974年 | 78篇 |
1972年 | 70篇 |
1971年 | 66篇 |
Objective
To determine whether differences in combination DTaP vaccine types at 2, 4 and 6?months of age were associated with mortality (all-cause or non-specific), within 30?days of vaccination.Design
Observational nationwide cohort study.Setting
Linked population data from the Australian Childhood Immunisation Register and National Death Index.Participants
Australian infants administered a combination trivalent, quadrivalent or hexavalent DTaP vaccine (DTaP types) between January 1999 and December 2010 at 2, 4 and 6?months as part of the primary vaccination series. The study population included 2.9, 2.6, & 2.3?million children in the 2, 4 and 6?month vaccine cohorts, respectively.Main outcome measures
Infants were evaluated for the primary outcome of all-cause mortality within 30?days. A secondary outcome was non-specific mortality (unknown cause of death) within 30?days of vaccination. Non-specific mortality was defined as underlying or other cause of death codes, R95 ‘Sudden infant death syndrome’, R96 ‘Other sudden death, cause unknown’, R98 ‘Unattended death’, R99 ‘Other ill-defined and unspecified cause of mortality’ or where no cause of death was recorded.Results
The rate of 30?day all-cause mortality was low and declined from 127.4 to 59.3 deaths per 100,000 person-years between 2 and 6?month cohorts. When compared with trivalent DTaP vaccines, no elevated risk in all-cause or non-specific mortality was seen with any quadrivalent or hexavalent DTaP vaccines, for any cohort.Conclusion
Use of routine DTaP combination vaccines with differing disease antigens administered during the first six months of life is not associated with infant mortality. 相似文献Methods: A retrospective cohort study of patients with IU who had a minimal follow-up of one year.
Results: 96 patients (174 eyes, 70% females) were included with a mean age at presentation of 30 years. Children constituted 38% of all patients. Mean follow- up was 64.9 months. Pars planitis was the most common form followed by sarcoidosis and multiple sclerosis. Cystoid macular edema (CME), cataract, epiretinal membrane and posterior synechiae were the most prevalent complications. Posterior synechiae, band keratopathy, cataract and papillitis at presentation were associated with worse presenting visual acuity (VA). Of the late-onset complications, glaucoma/ocular hypertension (OHT) was the most significantly associated with worse long-term VA. Most sight-threatening complications (namely CME and glaucoma) were diagnosed at presentation while late complications predominantly affected the posterior segment and included among others peripheral retinal elevations, vasoproliferative tumors, and vitreous hemorrhage. Median LogMAR VA improved at short-term and long-term follow-up, from 0.2 to 0.1 (p<0.001). Subgroup analysis revealed significant VA improvement for eyes with all the different complications except for eyes with glaucoma/OHT.
Conclusion: IU is a chronic low-grade uveitis that may be associated with protean early and late complications of the anterior or posterior segments or both. Optimal treatment regimens are imperative for the strict control of inflammation and proper management of complications thus allowing a favorable long-term prognosis. 相似文献